Zayed University

ZU Scholars
All Works
12-1-2021

The interrelationship and accumulation of cardiometabolic risk
factors amongst young adults in the United Arab Emirates: The
UAE Healthy Future Study
Fatima Mezhal
NYU Abu Dhabi

Abderrahim Oulhaj
Khalifa University of Science and Technology

Abdishakur Abdulle
NYU Abu Dhabi

Abdulla AlJunaibi
Zayed Military Hospital

Abdulla Alnaeemi
Zayed Military Hospital
Follow this and additional works at: https://zuscholars.zu.ac.ae/works
See next page for additional authors
Part of the Medicine and Health Sciences Commons

Recommended Citation
Mezhal, Fatima; Oulhaj, Abderrahim; Abdulle, Abdishakur; AlJunaibi, Abdulla; Alnaeemi, Abdulla; Ahmad,
Amar; Leinberger-Jabari, Andrea; Al Dhaheri, Ayesha S.; Tuzcu, E. Murat; AlZaabi, Eiman; Al-Maskari,
Fatma; Alanouti, Fatme; Alameri, Fayza; Alsafar, Habiba; Alblooshi, Hamad; Alkaabi, Juma; Wareth, Laila
Abdel; Aljaber, Mai; and Kazim, Marina, "The interrelationship and accumulation of cardiometabolic risk
factors amongst young adults in the United Arab Emirates: The UAE Healthy Future Study" (2021). All
Works. 4674.
https://zuscholars.zu.ac.ae/works/4674

This Article is brought to you for free and open access by ZU Scholars. It has been accepted for inclusion in All
Works by an authorized administrator of ZU Scholars. For more information, please contact scholars@zu.ac.ae.

Author First name, Last name, Institution
Fatima Mezhal, Abderrahim Oulhaj, Abdishakur Abdulle, Abdulla AlJunaibi, Abdulla Alnaeemi, Amar
Ahmad, Andrea Leinberger-Jabari, Ayesha S. Al Dhaheri, E. Murat Tuzcu, Eiman AlZaabi, Fatma Al-Maskari,
Fatme Alanouti, Fayza Alameri, Habiba Alsafar, Hamad Alblooshi, Juma Alkaabi, Laila Abdel Wareth, Mai
Aljaber, and Marina Kazim

This article is available at ZU Scholars: https://zuscholars.zu.ac.ae/works/4674

Mezhal et al.
Diabetology & Metabolic Syndrome
(2021) 13:140
https://doi.org/10.1186/s13098-021-00758-w

Diabetology &
Metabolic Syndrome
Open Access

RESEARCH

The interrelationship and accumulation
of cardiometabolic risk factors amongst young
adults in the United Arab Emirates: The UAE
Healthy Future Study
Fatima Mezhal1*, Abderrahim Oulhaj2, Abdishakur Abdulle1, Abdulla AlJunaibi3, Abdulla Alnaeemi4,
Amar Ahmad1, Andrea Leinberger‑Jabari1, Ayesha S. Al Dhaheri5, E. Murat Tuzcu6, Eiman AlZaabi7,
Fatma Al‑Maskari8,9, Fatme Alanouti10, Fayza Alameri11, Habiba Alsafar12,13,14, Hamad Alblooshi15,
Juma Alkaabi16, Laila Abdel Wareth17, Mai Aljaber18, Marina Kazim15, Micheal Weitzman19,
Mohammad Al‑Houqani20, Mohammad Hag Ali21, Naima Oumeziane15, Omar El‑Shahawy22, Rami H. Al‑Rifai8,
Scott Scherman22, Syed M. Shah8, Tom Loney23, Wael Almahmeed6, Youssef Idaghdour1, Luai A. Ahmed8,9† and
Raghib Ali1,24†

Abstract
Introduction: Similar to other non-communicable diseases (NCDs), people who develop cardiovascular disease
(CVD) typically have more than one risk factor. The clustering of cardiovascular risk factors begins in youth, early adult‑
hood, and middle age. The presence of multiple risk factors simultaneously has been shown to increase the risk for
atherosclerosis development in young and middle-aged adults and risk of CVD in middle age.
Objective: This study aimed to address the interrelationship of CVD risk factors and their accumulation in a large
sample of young adults in the United Arab Emirates (UAE).
Methods: Baseline data was drawn from the UAE Healthy Future Study (UAEHFS), a volunteer-based multicenter
study that recruits Emirati nationals. Data of participants aged 18 to 40 years was used for cross-sectional analysis.
Demographic and health information was collected through self-reported questionnaires. Anthropometric data and
blood pressure were measured, and blood samples were collected.
Results: A total of 5126 participants were included in the analysis. Comorbidity analyses showed that dyslipidemia
and obesity co-existed with other cardiometabolic risk factors (CRFs) more than 70% and 50% of the time, respec‑
tively. Multivariate logistic regression analysis of the risk factors with age and gender showed that all risk factors were
highly associated with each other. The strongest relationship was found with obesity; it was associated with four-fold
increase in the odds of having central obesity [adjusted OR 4.70 (95% CI (4.04–5.46)], and almost three-fold increase
odds of having abnormal glycemic status [AOR 2.98 (95% (CI 2.49–3.55))], hypertension (AOR 3.03 (95% CI (2.61–3.52))]
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and dyslipidemia [AOR 2.71 (95% CI (2.32–3.15)]. Forty percent of the population accumulated more than 2 risk fac‑
tors, and the burden increased with age.
Conclusion: In this young population, cardiometabolic risk factors are highly prevalent and are associated with each
other, therefore creating a heavy burden of risk factors. This forecasts an increase in the burden of CVD in the UAE.
The robust longitudinal design of the UAEHFS will enable researchers to understand how risk factors cluster before
disease develops. This knowledge will offer a novel approach to design group-specific preventive measures for CVD
development.
Keywords: Cardiovascular disease, Cardiometabolic risk factors, Obesity, Dysglycemia, Dyslipidemia, Hypertension,
Central obesity, Metabolic Syndrome

Introduction
Cardiovascular disease (CVD) remains the number one
cause of death and disability in the world. About 85% of
CVD deaths are attributable to ischemic heart disease
and stroke [1]. There are multiple risk factors associated
with CVD. The most common ones include general obesity (based on BMI), central obesity or abdominal obesity,
hyperglycemia, dyslipidemia, and high-blood pressure.
The prevalence of the cardiometabolic risk factors (CRFs)
associated with non-communicable diseases (NCDs) has
increased in the UAE and will continue to increase, as
demonstrated by many studies and as predicted by projections and future estimates [2].
Having one risk factor does not necessarily lead to
developing CVD. Similar to other NCDs, people who
develop ischemic heart disease typically have more than
one risk factor. The clustering of cardiovascular risk factors begins in youth, and continues during young adulthood and middle age [3, 4]. The presence of multiple risk
factors simultaneously has been shown to increase the
risk for atherosclerosis development in young and middle-aged adults and risk of CVD in middle age [5].
For example, Wilson et al.’s [6]study estimated that
accumulating three or more risk factors was associated with around a 2.4-fold increase in men and 5.9-fold
increase in women in the risk of coronary heart disease
after 16 years of follow-up. Additionally, they showed
that having 3 or more risk factors in the general population, was attributable to about 20% of coronary events
in men and 48% in women. Another study on hypertensive individuals without CVD, showed that accumulating three or more risk factors increased the relative risk
of developing cardiovascular events from 2.07 (95% CI
1.86–2.30) to 2.80 (95% CI 2.48–3.17) when compared to
having only one risk factor, in a 6-year follow up [7].
Interrelationships between pairs of risk factors have
been studied previously. Weight increase was reported to
be associated with hyperlipidemia, glycaemia, and hypertension in young adults [8]. Hypertension was reported
to be associated with type 2 diabetes [9]. In addition,
insulin resistance was associated with hypertension [10].

Other studies reported an increase in incident diabetes
and hypertension following dyslipidemia [11, 12].
Since NCDs are caused by the interplay of risk factors and their accumulation, it is important to study how
these risk factors are linked and how they accumulate
before a chronic disease is established. The majority of
local research in UAE has studied the risk factors individually. Most of the epidemiological studies are pre-dated
and recruited a sample from a particular geographic
location (e.g. city) or from specific healthcare settings.
Although it is well-established that chronic diseases start
developing in younger adults, there are limited studies in
the UAE on the burden of risk factors in young adults.
This study aimed to address the accumulation of cardiometabolic risk factors (CRFs) and their interrelationship
in a large sample of adults below 40 years.

Methods
Study sample

The study participants were from the UAE Healthy
Future Study (UAEHFS) [13]. The UAEHFS is an ongoing
population-based prospective cohort study that aims to
explore risk factors for NCDs. Emirati adults are invited
to participate at multiple centers across major cities in
the UAE.The study was based on the cross-sectional analysis of available baseline data from the UAEHFS cohort,
recruited between February 2016 and December 2018.
Subjects were nationals aged 18 to 40 years. All participants provided informed consent. Participants who
reported any acute infection at the time of recruitment
and pregnant women were excluded from the study. This
study was approved by the Abu Dhabi Health Research
and Technology Committee (ref. DOH/HQD/2020/516).
Additional information on the UAEHFS methodology is
published elsewhere [13].
Data collection

Participants answered a self-completed questionnaire that collected socio-demographic, health, and
lifestyle information. Participants underwent physical
measurements including height, weight, waist and hip
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circumferences as well as blood pressure measurements.
Blood samples were collected to measure glycated hemoglobin (HbA1c), low-density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, total
cholesterol, and triglycerides. Only fasting samples were
used to measure blood glucose.
Cardiometabolic risk factors criteria

Body mass index (BMI) was categorized according to
the WHO definitions. A BMI less than 25.0 kg/m2 was
considered normal. A BMI between 25.0 and 29.9 kg/m2
was considered overweight. And a BMI ≥ 30.0 kg/m2 was
classified as obese.
Dysglycemia, or abnormal glycemic status, was
defined as prediabetes or diabetes. Cut-offs were set
at HbA1c ≥ 5.7% and < 6.5%, and fasting blood glucose (FBG) ≥ 100 and < 126 mg/dL for prediabetes,
while diabetes was classified as having HbA1c ≥ 6.5%,
FBG ≥ 126 mg/dl and/or reporting diabetes or taking
antidiabetic medication [14, 15].
Dyslipidemia was defined as either self-reported history of abnormal cholesterol level, or taking a lipid-controlling medication or having an abnormal level of any
of the following; LDL cholesterol level of ≥ 130 mg/dL,
HDL cholesterol level of ≤ 40 mg/dL for men or ≤ 50 mg/
dL for women, total cholesterol ≥ 200 mg/dL or triglycerides ≥ 150 mg/dL for fasting samples and ≥ 175 mg/dL
for random samples [16, 17].
Elevated blood pressure, or hypertension, was defined
as having two consecutive blood pressure readings
of ≥ 140 mmHg systolic and/or ≥ 90 mmHg diastolic
according to the American Heart Association guidelines [18]. Hypertension was also defined as having
self-reported “hypertension” on the questionnaire and/
or whether they are taking blood pressure-controlling
medication.
Abdominal obesity (or central obesity) was indicated
if the waist-to-hip ratio ≥ 0.85 for women and ≥ 0.90 for
men [19].
Statistical analyses

Baseline characteristics of the study participants were
presented overall and by gender. Categorical data was
presented as frequencies and percentages and continuous variables were presented as means ± standard deviation. The frequencies and percentages were tested for
significance of any differences in distribution between
two or more groups using chi-square test. For continuous
variables, differences in means were measured by Welch
t-tests. The prevalence was adjusted for age using logistic
models and presented with 95% confidence intervals (CI).
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The burden of CRFs was defined and estimated as the
number of risk factors per individual. The maximum
number of risk factors was five per individual. CRFs were
then grouped to form two burden groups; “0–1” and
“ ≥ 2” risk factors. Multivariate logistic regression analyses were performed to measure the associations between
CRFs, adjusted for age and gender. Adjusted Odds Ratios
(OR) with their 95% CIs were reported. The analyses
were performed using Stata 15 software [20]. The significance level of the statistical tests was set at 5%.

Results
A total of 5167 subjects aged between of 18 and 40 years
were recruited from February 2016 to December 2018.
Questionnaire data was available for up to 85% of the
participants, anthropometric data and blood pressure
was available for 94% of the sample, and blood biomarkers data was available for 98% of the sample. More than
80% of the population had complete data points. Table 1
represents the age-adjusted cardiometabolic characteristics of the study population.
Almost two-thirds of the sample was classified as either
overweight or obese, 30.1% [95% CI(28.8−31.4)] and
26.5% [95% CI (25.2–27.7)]; respectively. Men had higher
prevalence than women (p < 0.001). Both prediabetes and
diabetes prevalence were estimated as 8.2% [95%CI (7.4–
8.9)]and 3.5% [95%CI (3.0–4.0)]; respectively. Abnormal glycemic markers were higher in men than women
(p < 0.001). Moreover, abnormal lipid biomarkers were
consistently higher in men than women (p < 0.001), contributing to a total dyslipidemia prevalence of 68.0% [95%
CI (66.3–69.7)] in men and 54.2% [95% CI (52.0–56.5)] in
women (p < 0.001).
Hypertension, based on blood pressure measurements and self-report, was estimated as 22.4% [95%CI
(21.2–23.6)]; significantly higher in men than women;
30.9% [95%CI (29.2–32.6)] and 9.2% [95%CI (7.8–10.5)]
(P < 0.001); respectively. Finally, abdominal obesity was
estimated as 22.5% [95%CI (21.3–23.8)] in the whole
sample and the prevalence was more than double in men
compared to women (P < 0.001).
Table 2 presents a summary of the prevalence of cardiometabolic comorbidity; having two cardiovascular risk factors simultaneously. Among the people with
dyslipidemia, more than 70% had another coexisting
metabolic risk factor. The following most common coexisting risk factor was obesity. More than 50% of obese
participants also have had dysglycemia or central obesity. Interestingly, among dysglycemic participants, only
24% were also classified as obese, and 23% classified as
hypertensive.
Associations among the risk factors were investigated.
Table 3 presents the associations between the five CRFs
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Table 1 Age-adjusted prevalence % of cardiometabolic risk factors of UAEHFS participants
Overall
N = 5126

Men, N = 3202 (62%)

Women, N = 1965 (38%)

P-value

Age (years), mean (SD)

25.7 (6.2)

26.4 (5.9)

24.5 (6.3)

< 0.001

Overweight

30.1 (28.8–31.4)

34.7 (33.0–36.4)

23.1 (21.2–25.0)

< 0.001

Obesity

26.5 (25.2–27.7)

29.7 (28.0–31.4)

21.6 (19.7–23.5)

< 0.001

Prediabetes

8.2 (7.4–8.9)

10.1 (9.1–11.2)

5.2 (4.1–6.2)

< 0.001

Diabetes

3.5 (3.0–4.0)

3.8 (3.1–4.5)

3.1 (2.3–3.9)

< 0.001

Dysglycemia

11.7 (10.8–12.7)

14 (12.7–15.2)

8.3 (7.0–9.6)

< 0.001

High LDL

34.5 (33.2–35.9)

42.1 (40.3–43.9)

22.9 (20.9–24.8)

< 0.001

Low HDL

43.7 (42.4–45.1)

45.4 (43.6–47.1)

41.1 (38.9–43.3)

High total cholesterol

32.8 (31.4–34.1)

37.2 (35.4–38.9)

26.0 (24.0–28)

< 0.001

High Triglycerides

21.4 (20.2–22.6)

26.7 (25.1–28.3)

13.5 (11.9–15.1)

< 0.001

Dyslipidemia

62.7 (61.3–64)

68 (66.3–69.7)

54.2 (52–56.5)

< 0.001

Hypertension

22.4 (21.2–23.6)

30.9 (29.2–32.6)

9.2 (7.8–10.5)

< 0.001

Central obesity

22.5 (21.3–23.8)

29.6 (27.9–31.3)

12.5 (10.9–14.0)

< 0.001

0.003

Age is presented as mean years (standard deviation). Data is presented as prevalence % (confidence interval)
Overweight and obesity were defined as having a BMI between 25.0 and 29.9 kg/m2 and BMI ≥ 30 kg/m2, respectively. Dysglycemia was defined as having
HbA1c ≥ 5.7%, and/or FBG ≥ 100 mg/dl, and/or self-reporting diabetes or taking antidiabetic medication. Dyslipidemia was defined as having any abnormality across
lipid markers (LDL ≥ 130 mg/dl, HDL ≤ 40 mg/dl for men or ≤ 50 mg/dl for women, total cholesterol ≥ 200 mg/dl or triglycerides ≥ 150 mg/dl for fasting samples
and ≥ 175 mg/dl for random samples) and/or self-reporting abnormal cholesterol or taking lipid-controlling medication. Hypertension was defined as ≥ 140 mmhg
systolic and/or ≥ 90 mmhg diastolic pressure and/or self-reporting hypertension or taking blood pressure-controlling medication. Central obesity was defined as
having waist-to-hip ratio as ≥ 0.85 for women and ≥ 0.90 for men

Table 2 The prevalence of comorbidity of cardiometabolic risk factors in the UAEHFS participants
Obesity

Dysglycemia

Dyslipidemia

Hypertension
38.9 (36–41.8)

Central obesity

48.9 (46.2–51.6)

37.9 (34.1–41.8)

31.1 (29.5–32.8)

Hypertension

39.4 (36.8–42.1)

40.8 (37–44.7)

27.8 (26.3–29.5)

Dyslipidemia

79.4 (77.2–81.5)

77.3 (73.9–80.4)

Dysglycemia

24 (21.8–26.4)

Obesity

51.7 (47.8–55.6)

Central obesity

36.6 (33.8–39.4)
75.2 (72.6–77.6)

79.1 (76.6–81.4)

15.7 (14.5–17)

22.8 (20.5–25.4)

19.7 (17.6–22.1)

35.1 (33.3–36.8)

47.4 (44.4–50.4)

54.9 (52–57.8)

Data is presented as prevalence % (95% CI) for co-existing CRFs

Table 3 Odd ratios of the associations between the cardiometabolic risk factors adjusted for age and sex
Obesity

Dysglycemia

Dyslipidemia

Hypertension
1.85 (1.58–2.17)

Central obesity

4.70 (4.04–5.46)

1.57 (1.29–1.9)

2.18 (1.85–2.56)

Hypertension

3.03 (2.61–3.52)

2.32 (1.92–2.79)

1.81 (1.54–2.12)

Dyslipidemia

2.71 (2.32–3.15)

1.85 (1.51–2.26)

Dysglycemia

2.98 (2.49–3.55)

Dyslipidemia

Data is presented as odds ratios (95% CI). Multivariate models adjusted for age and gender only. For each risk factor, the reference groups were those without that risk
factor

adjusting for age and gender. The strongest relationship
was captured with obesity. For instance, obesity was associated with more than four-fold increase in the odds of
having central obesity [OR 4.70 95%CI (4.04–5.46)],
and almost three-fold increase in the odds of having
abnormal glycemic status [OR 2.98 95%CI (2.49–3.55)],

hypertension [OR 3.03 95%CI (2.61–3.52)], and dyslipidemia [OR 2.71 95% CI (2.32–3.15)].
The burden of CRFs was measured as the number of
risk factors accumulated per subject. Around a quarter of the population (23.8%) had zero risk factors. The
remaining population had a range from 1 to 5 risk factors. The majority of the sample had either 1 risk factor
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Fig. 1 Age-adjusted prevalence of number of accumulated
cardiometabolic risk factors in the whole sample

(36.2%) or 2 risk factors (21.4%) as displayed in Fig. 1.
The distribution of number of risk factors in men and
women is visualized in Fig. 2. Males in this sample had
more risk factors than females; 83% of men had at least
one risk factor versus 64% of women (p < 0.001).
Figure 3 shows the distribution of the burden of the
CRFs dichotomized to “0–1 RFs” and “ ≥ 2 RFs” within
age groups. About sixty percent of the total population had 0–1 risk factors.The proportion of accumulated risk factors increased in the older age groups
(p < 0.001). This was similar in men and women.
Figure 4 represents the most common CRFs in the
youngest age groups, those below the age of 25 years.
In men, the most common CRF was dyslipidemia,
where it was reported in 54.6% of the male population,
followed by hypertension, obesity, central obesity then
dysglycemia. In women, however, the rankings differed. The most common CRF was dyslipidemia, followed by obesity, central obesity, hypertension then
dysglycemia.

40

35.9

35

34.9

37.4

%

30
25
20

Discussion
This study presents the first comprehensive description
of the accumulation of common CVD risk factors and
their interrelationship in a large sample of young Emirati
adults. It is well established that before CVD develops,
multiple risk factors co-exist. The clustering of the cardiovascular risk factors starts in adolescence and early
adulthood [4]. In this study, we investigated the extent of
co-existence of these risk factors and how often do they
accumulate in young adults between 18 and 40 years.
The study showed interesting patterns in this population. We found that dyslipidemia coexisted with another
metabolic abnormality more than 75% of the time, followed by obesity and central obesity. Interestingly, in
the dysglycemic group, comorbidity was least evident. In
contrast, in another national study, Hajat et al. showed
that cardiometabolic comorbidity was most evident in
diabetic participants [21].
All associations were found to be significant after
adjusting for age and gender (Table 3). The associations
between pairs of CRFs indicate that these risk factors
cluster differently in people. Overall, obesity had the
strongest relationship with all metabolic abnormalities.
Baynouna et al. [22] showed that the strongest interrelationship between risk factors was detected with obesity
and hypertension, with an odd ratio 1.9 (95%CI 1.2 – 3.0),
and with high LDL, odd ratio 1.7 (95%CI 1.1–2.5).
One quarter of the total sample population had no
CRFs. Grouping the burden into two categories, 0–1
and 2 or more risk factors yielded a 60–40 ratio; 60%
had one or no risk factor, and 40 had two or more risk
factors. Almost half (47.8%) of the male population
in this study had two or more risk factors, while only
28.1% of the female’s population did. This should be
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Fig. 2 Age- adjusted prevalence of accumulated cardiometabolic risk factors in men and women
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Fig. 3 Burden of cardiometabolic risk factors in different age groups

Fig. 4 Prevalence of risk factors in UAEHFS below the age of 25 years
in men and women

considered as alarming as this is a young population
sample with aged between 18–40 years. Surprisingly,
even 24% of the subjects in the youngest age group
18–19 years had already developed 2 or more CRFs.
Focusing more on the youngest age groups (below
25 years), we have found that CRFs prevalence differ
across men and women. Figure 4 shows that in men,
dyslipidemia and hypertension are the highest 2 CRFs
among young men, while obesity ranks third. In young
women, hypertension rates were much lower and
ranked fourth, after dyslipidemia, obesity and central
adiposity. The finding that dyslipidemia has the highest prevalence and also almost always co-existing with
other CRFs is in line with Paynter et al.‘s finding [5].
They have reported that dyslipidemia is more likely to
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occur first in a cluster of risk factors, more than hypertension, obesity and diabetes. These findings strongly
suggest that dyslipidemia screening in early adulthood
may be a good target for risk factor accumulation and
therefore CVD prevention.
A recent report from the UAE National Health Survey estimated that 49.5% of the 18–44 years’ population
had three or more of the following risk factors: smoking, inadequate diet, insufficient physical activity, overweight, or raised blood pressure [23]. The survey results
indicated that there were more men than women with
such criteria (54.4 vs. 45.1% respectively). However, this
estimation was not limited to Emiratis and included burden of non-metabolic risk factors. In another report on
the burden of cardiovascular risk factors in 33,000 young
military men, it was estimated that 24% had at least 2 risk
factors [24]. This prevalence probably underestimates
the burden at population level as the sample subjects
were military men, which have differences in age structure, social and behavioral characteristics, and health and
physical fitness standards required for their occupation.
We also found that the proportion of people having 2 or more risk factors increased with age. This finding parallels the established fact that cardiovascular risk
increases with age. It is well known that aging increases
the risk for CVD as there are multiple structural and
functional alterations that occur throughout a lifespan
[25]. For instance, changes at the molecular level, such as
the increase in oxidative stress can lead to obesity, diabetes, and frailty, which is called “cardiovascular aging”
[26].
The main strength of this study is the ability to asses
CVD risk factors in young adults in large populationbased sample size. This study focused on young adults,
who are often underrepresented in the context of noncommunicable disease studies, especially CVD. Cardiovascular risk factors definitions were thorough and
included objective and subjective measures for a more
concise disease-definition criteria. Blood samples and
measurements were collected in a standardized procedure to ensure consistent quality and reduce the risk of
information bias.
In this study, we defined dyslipidemia as having any
abnormality across the 4 lipids biomarkers: LDL, HDL,
total cholesterol, and triglycerides, as well as reporting a
medical diagnosis and/or taking medication. This definition is recommended by the ATP 3 guidelines for persons
above 20 years old [27]. Besides the broad definition, we
used random non-fasting samples, which recent reports
have shown are equally acceptable [28, 29].
Most epidemiological studies are prone to having selection bias that can affect the external validity
of the study. The main weakness of this study is that it

Mezhal et al. Diabetology & Metabolic Syndrome

(2021) 13:140

is volunteer-based recruitment of participants, which
therefore potentially affects the representativeness of
the study sample. However this is common to most large
cohort studies which are volunteer-based convenience
samples, but provided that there is wide range of exposures within the cohort, this is not a significant limitation
to understanding the relationship between exposures and
outcomes.

Conclusion
Studying the major cardiovascular risk factors and how
they link and accumulate to each other in a young sample of Emiratis provides a novel insight. Here, we showed
how the major risk factors are highly prevalent and start
accumulating very early in age, even in those below
25 years of age. The population’s increasing burden of
risk factors forecasts an increase in the future incidence
of CVD. This calls for taking preventive measures that
must be designed for the youth in schools and universities. Also, comorbidity analysis in this study showed that
dyslipidemia co-exists with other cardiometabolic abnormalities. Such patients must be additionally screened
for other risk factors and must be made aware that they
would be more prone for having another metabolic
abnormality.
Finally, addressing the high burden of risk factors is
only a first step in understanding how clustering will
affect the incidence of CVD. Studying the basis for risk
factor clustering will provide insight into the pathogenesis of atherosclerosis and it has implications for the prevention of coronary disease.
Abbreviations
NCDs: Non-communicable disease; CVD: Cardiovascular disease; UAE: United
Arab Emirates; UAEHFS: UAE Healthy Future Study; CRFs: Cardiometabolic
risk factors; AOR: Adjusted odds ratio; OR: Odds ratio; CI: Confidence interval;
HbA1c: Hemoglobin A1c, glycated hemoglobin; LDL: Low-desity lipoprotein;
HDL: High-density lipoprotein; BMI: Body mass index; WHO: World Health
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